naringenin has been researched along with Alloxan Diabetes in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.14) | 29.6817 |
| 2010's | 20 (71.43) | 24.3611 |
| 2020's | 6 (21.43) | 2.80 |
| Authors | Studies |
|---|---|
| Hwangbo, Y; Kim, JH; Kim, YJ; Park, S; Park, SJ; Sim, KS | 1 |
| Gao, J; Kang, Z; Lin, P; Yin, D; Zeng, J; Zhang, X; Zhu, B | 1 |
| Latiff, AA; Mardiana, AA; Sahema, ZCT; Santhana, RL; Syed Ahmad Fuad, SB; Zaidun, NH | 1 |
| Essop, MF; Mato Mofo, EP; Owira, PMO | 1 |
| Bansal, S; Chopra, K; Kuhad, A; Kumar, A; Singh, P | 1 |
| Kulkarni, YA; Suryavanshi, SV | 1 |
| Bai, YF; Fan, XY; Fu, JQ; Sheng, H; Wang, SW; Weng, YY; Zhang, F; Zheng, F | 1 |
| Chakraborti, AS; Kundu, PP; Maity, S; Mukhopadhyay, P | 1 |
| Abdel Azeem, MN; Abdel-Twab, SM; Ahmed, OM; Hassan, MA | 1 |
| C D, N; M S, S | 1 |
| Ahmed, MM; Al-Dosari, DI; Al-Rejaie, SS; Alhomida, AS; Ola, MS | 1 |
| Bhattacharya, B; De, A; Keshari, AK; Kumar, D; Kumar, P; Maity, B; Prakash, A; Rai, A; Raj, V; Rawat, A; Saha, S; Samanta, A; Singh, AK | 1 |
| Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Wu, Q; Zhang, J | 1 |
| Kaczmarczyk-Sedlak, I; Wojnar, W; Zych, M | 1 |
| Chen, R; Cheng, O; Ding, S; Huang, B; Huang, J; Jiang, Q; Qiu, H; Zhang, J; Zou, X | 1 |
| Al-Oanzi, ZH | 1 |
| Annadurai, T; Geraldine, P; Thomas, PA | 1 |
| Kumar, V; Priscilla, DH; Roy, D; Suresh, A; Thirumurugan, K | 1 |
| Fazeli, F; Hasanein, P | 1 |
| Ahmed, F; Banerjee, S; Roy, S; Saha, U | 1 |
| Gregorović, G; Končić, MZ; Oršolić, N; Sirovina, D | 1 |
| Chen, L; Duan, Q; Li, H; Liu, H; Peng, H; Peng, R; Sun, Y; Wei, L; Wen, L; Wu, T; Yan, N; Zhang, Z; Zhou, Q | 1 |
| Anuradha, CV; Kannappan, S | 1 |
| Dikić, D; Gajski, G; Garaj-Vrhovac, V; Oršolić, N; Prskalo, ZŠ; Sirovina, D | 1 |
| Annadurai, T; Geraldine, P; Hsu, MJ; Joseph, T; Muralidharan, AR; Thomas, PA | 1 |
| Aswar, M; Bhutada, P; Kaulaskar, S; Otari, K; Rahigude, A | 1 |
| Che, CT; Cheng, CH; Lau, CB; Leung, PS; Li, JM | 1 |
| Binnie, M; Cigarroa-Vázquez, P; Estrada-Soto, S; García-Jiménez, S; León-Rivera, I; Navarrete-Vázquez, G; Ortiz-Andrade, RR; Sánchez-Salgado, JC; Villalobos-Molina, R; Webster, SP | 1 |
28 other study(ies) available for naringenin and Alloxan Diabetes
| Article | Year |
|---|---|
Naringenin and Phytoestrogen 8-Prenylnaringenin Protect against Islet Dysfunction and Inhibit Apoptotic Signaling in Insulin-Deficient Diabetic Mice.
Topics: Animals; Apoptosis; Blood Glucose; Diabetes Mellitus, Experimental; Estrogen Receptor alpha; Estrogens; Flavanones; Glucose; Hypoglycemic Agents; Insulin; Mice; Phytoestrogens; Streptozocin | 2022 |
Naringenin protects pancreatic β cells in diabetic rat through activation of estrogen receptor β.
Topics: Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Estrogen Receptor beta; Estrogens; Glucose; Insulin; Insulin-Secreting Cells; Rats; Receptors, Estrogen | 2023 |
Effects of naringenin on vascular changes in prolonged hyperglycaemia in fructose-STZ diabetic rat model.
Topics: Animals; Diabetes Mellitus, Experimental; Drug Synergism; Flavanones; Fructose; Hyperglycemia; Lipid Peroxidation; Lipids; Male; Malondialdehyde; Metformin; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Streptozocin | 2019 |
Citrus fruit-derived flavonoid naringenin and the expression of hepatic organic cation transporter 1 protein in diabetic rats treated with metformin.
Topics: Animals; Blood Glucose; Citrus; Diabetes Mellitus, Experimental; Flavanones; Flavonoids; Hypoglycemic Agents; Lactic Acid; Liver; Male; Metformin; Organic Cation Transporter 1; Rats; Rats, Sprague-Dawley; Streptozocin | 2020 |
Naringenin ameliorates diabetic neuropathic pain by modulation of oxidative-nitrosative stress, cytokines and MMP-9 levels.
Topics: Analgesics; Animals; Cytokines; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Flavanones; Matrix Metalloproteinase 9; Neuralgia; Oxidative Stress; Pain Measurement; Phytotherapy; Random Allocation; Rats; Rats, Wistar; Streptozocin | 2020 |
Combination of Naringenin and Lisinopril Ameliorates Nephropathy in Type-1 Diabetic Rats.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Flavanones; Kidney; Lisinopril; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Streptozocin | 2021 |
Inhibition of histone acetyltransferase by naringenin and hesperetin suppresses Txnip expression and protects pancreatic β cells in diabetic mice.
Topics: Acetylation; Animals; Carrier Proteins; Citrus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Flavanones; Hesperidin; Histone Acetyltransferases; Histones; Hypoglycemic Agents; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Rats; Thioredoxins | 2021 |
Alginate coated chitosan core-shell nanoparticles for efficient oral delivery of naringenin in diabetic animals-An in vitro and in vivo approach.
Topics: Administration, Oral; Alginates; Animals; Chitosan; Diabetes Mellitus, Experimental; Drug Carriers; Flavanones; Glucuronic Acid; Hexuronic Acids; Nanoparticles; Particle Size; Rats | 2017 |
Navel orange peel hydroethanolic extract, naringin and naringenin have anti-diabetic potentials in type 2 diabetic rats.
Topics: Animals; Blood Glucose; Citrus sinensis; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Ethanol; Flavanones; Fruit; Hypoglycemic Agents; Male; Plant Extracts; Rats; Streptozocin; Water | 2017 |
Influence of quercetin, naringenin and berberine on glucose transporters and insulin signalling molecules in brain of streptozotocin-induced diabetic rats.
Topics: Animals; Berberine; Blood-Brain Barrier; Brain; Diabetes Mellitus, Experimental; Flavanones; Glucose Transport Proteins, Facilitative; Insulin; Male; Neuroprotective Agents; Phosphatidylinositol 3-Kinases; Quercetin; Rats; Rats, Wistar; Signal Transduction; Streptozocin | 2017 |
Flavonoid Naringenin Attenuates Oxidative Stress, Apoptosis and Improves Neurotrophic Effects in the Diabetic Rat Retina.
Topics: Animals; Antioxidants; Apoptosis; bcl-2-Associated X Protein; Blood Glucose; Brain-Derived Neurotrophic Factor; Caspase 3; Diabetes Mellitus, Experimental; Diabetic Retinopathy; Disease Models, Animal; Flavanones; Flavonoids; Glutathione; Hypoglycemic Agents; Male; Nerve Tissue Proteins; Oxidative Stress; Rats; Rats, Wistar; Retina; Synaptophysin; Thiobarbituric Acid Reactive Substances | 2017 |
Isolated mangiferin and naringenin exert antidiabetic effect via PPAR
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Flavanones; Glucose Transporter Type 4; Glycogen; Hypoglycemic Agents; Insulin; Lipids; Liver; Male; Molecular Docking Simulation; Oxidative Stress; Pancreas; PPAR gamma; Protein Structure, Tertiary; Rats; Salacia; Signal Transduction; Streptozocin; Xanthones | 2018 |
Naringenin exhibits the protective effect on cardiac hypertrophy via EETs-PPARs activation in streptozocin-induced diabetic mice.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Flavanones; Male; Myocardium; Peroxisome Proliferator-Activated Receptors; Up-Regulation | 2018 |
Antioxidative effect of flavonoid naringenin in the lenses of type 1 diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Catalase; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Flavanones; Flavonoids; Glutathione; Glutathione Peroxidase; Glutathione Reductase; Hypoglycemic Agents; Lens, Crystalline; Lipid Peroxidation; Male; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Streptozocin; Superoxide Dismutase | 2018 |
Activation of 20-HETE/PPARs involved in reno-therapeutic effect of naringenin on diabetic nephropathy.
Topics: Animals; Cell Line; Cell Proliferation; Cytochrome P-450 CYP4A; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Diet, High-Fat; Female; Flavanones; Glucose; Hydroxyeicosatetraenoic Acids; Kidney; Mice; Peroxisome Proliferator-Activated Receptors; Rats; Streptozocin; Up-Regulation | 2019 |
Erectile dysfunction attenuation by naringenin in streptozotocin-induced diabetic rats.
Topics: Animals; Cyclic GMP; Diabetes Complications; Diabetes Mellitus, Experimental; Ejaculation; Erectile Dysfunction; Flavanones; Humans; Male; Oxidative Stress; Penile Erection; Rats; Spermatogenesis; Spermatozoa; Streptozocin; Testis; Testosterone | 2019 |
Ameliorative effect of naringenin on hyperglycemia-mediated inflammation in hepatic and pancreatic tissues of Wistar rats with streptozotocin- nicotinamide-induced experimental diabetes mellitus.
Topics: Animals; Antioxidants; C-Reactive Protein; Cytokines; Diabetes Mellitus, Experimental; Flavanones; Hepatitis; Hyperglycemia; Inflammation Mediators; Male; Niacinamide; Pancreatitis; Rats; Rats, Wistar | 2013 |
Naringenin inhibits α-glucosidase activity: a promising strategy for the regulation of postprandial hyperglycemia in high fat diet fed streptozotocin induced diabetic rats.
Topics: Animals; Binding Sites; Blood Glucose; Diabetes Mellitus, Experimental; Diet, High-Fat; Enzyme Activation; Flavanones; Glycoside Hydrolase Inhibitors; Humans; Hyperglycemia; Intestines; Ligands; Male; Models, Molecular; Molecular Docking Simulation; Rats; Rats, Wistar; Streptozocin | 2014 |
Role of naringenin in protection against diabetic hyperalgesia and tactile allodynia in male Wistar rats.
Topics: Administration, Oral; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Flavanones; Hyperalgesia; Hypoglycemic Agents; Male; Rats, Wistar; Superoxide Dismutase | 2014 |
Naringenin ameliorates streptozotocin-induced diabetic rat renal impairment by downregulation of TGF-β1 and IL-1 via modulation of oxidative stress correlates with decreased apoptotic events.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Dose-Response Relationship, Drug; Flavanones; Hypoglycemic Agents; Interleukin-1; Kidney; Male; Oxidative Stress; Rats, Wistar; Signal Transduction; Streptozocin; Time Factors; Transforming Growth Factor beta1 | 2016 |
Naringenin ameliorates pathological changes in liver and kidney of diabetic mice: a preliminary study.
Topics: Animals; Anti-Ulcer Agents; Diabetes Complications; Diabetes Mellitus, Experimental; Flavanones; Kidney; Lipid Peroxidation; Liver; Male; Mice | 2016 |
Naringenin Ameliorated Kidney Injury through Let-7a/TGFBR1 Signaling in Diabetic Nephropathy.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Flavanones; Kidney; Male; MicroRNAs; Protein Serine-Threonine Kinases; Rats; Rats, Sprague-Dawley; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Signal Transduction | 2016 |
Naringenin enhances insulin-stimulated tyrosine phosphorylation and improves the cellular actions of insulin in a dietary model of metabolic syndrome.
Topics: Animals; Diabetes Mellitus, Experimental; Diet; Flavanones; Fructose; Glycogen; Hypoglycemic Agents; Insulin; Liver; Male; Metabolic Syndrome; Muscle, Skeletal; Phosphorylation; Phytotherapy; Protein Processing, Post-Translational; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Rats; Rats, Wistar; Tyrosine | 2010 |
DNA-protective effects of quercetin or naringenin in alloxan-induced diabetic mice.
Topics: Animals; Antioxidants; Blood Glucose; Comet Assay; Diabetes Mellitus, Experimental; DNA; DNA Damage; Female; Flavanones; Hypoglycemic Agents; Macrophages; Male; Mice; Micronucleus Tests; Organ Specificity; Oxidative Stress; Peritoneal Cavity; Quercetin; Survival Analysis | 2011 |
Antihyperglycemic and antioxidant effects of a flavanone, naringenin, in streptozotocin-nicotinamide-induced experimental diabetic rats.
Topics: Animals; Antioxidants; Blood Glucose; Diabetes Mellitus, Experimental; Flavanones; Glycated Hemoglobin; Hypoglycemic Agents; Insulin; Male; Oxidative Stress; Pancreas; Rats; Rats, Wistar; Streptozocin | 2012 |
Participation of antioxidant and cholinergic system in protective effect of naringenin against type-2 diabetes-induced memory dysfunction in rats.
Topics: Animals; Antioxidants; Blood Glucose; Body Weight; Cholinesterase Inhibitors; Cholinesterases; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dietary Fats; Donepezil; Estrogen Antagonists; Fat Emulsions, Intravenous; Flavanones; Glutathione; Hypoglycemic Agents; Indans; Lipid Peroxidation; Male; Memory Disorders; Nitric Oxide; Parasympathetic Nervous System; Pioglitazone; Piperidines; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Thiazolidinediones | 2012 |
Inhibition of intestinal and renal Na+-glucose cotransporter by naringenin.
Topics: Animals; Diabetes Mellitus, Experimental; Flavanones; Glucose; Intestine, Small; Kidney Cortex; Male; Microvilli; Phlorhizin; Rabbits; Rats; Rats, Wistar; Sodium-Glucose Transport Proteins | 2006 |
Antidiabetic and toxicological evaluations of naringenin in normoglycaemic and NIDDM rat models and its implications on extra-pancreatic glucose regulation.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Flavanones; Glucose Tolerance Test; Glyburide; Hypoglycemic Agents; Lethal Dose 50; Male; Mice; Random Allocation; Rats; Rats, Wistar; Triglycerides | 2008 |